Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction
Clinical trial NCT03843515 · UNKNOWN
Trial details
- NCT number
- NCT03843515
- Sponsor
- Amsterdam UMC, location VUmc
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-11
- Primary completion
- 2021-11-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.